Ashvattas Life Sciences LLP

Ashvattas Life Sciences LLP - pharma in Nashik, Maharashtra, India. Directors, charges & compliance details.
LLPIN AAY-5221 Incorporated 09 September 2021 ROC Mumbai HQ Nashik, Maharashtra, India
Active Limited Liability Partnership pharma DPIIT Startup MSME · Small
Data last updated
Revenue · FY 2023
₹10.11 Cr
▲ 162% YoY
Net profit · FY 2023
₹39.06 Lakh
Net margin 3.9%
EBITDA · FY 2023
₹44.86 Lakh
EBITDA margin 4.4%
Contribution obligation
₹1 Lakh
As per LLP agreement
Open charges
₹3.5 Cr
Secured borrowings
LLP age
5 yrs
Est. 2021
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered

About Ashvattas Life Sciences LLP

Data last updated:

Ashvattas Life Sciences LLP is a limited liability partnership (LLP) based in Nashik, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 September 2021 and has been in existence for over 5 years.

The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAY-5221. Its GSTIN is 27ABWFA4241J1Z2 (Maharashtra).

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Rajat Gotulal Agrawal and Tilak Rahul Agrawal.

Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at Pl No. Nalanda Co Op Hsg Behind Bhimnagar Jail Road Nashik Road, Maharashtra, India – 422101.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹10.11 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹39.06 Lakh (net margin 3.9%) and EBITDA of ₹44.86 Lakh (EBITDA margin 4.4%).

As per MCA filings, the LLP has open charges of ₹3.5 Cr on record.

Ashvattas Life Sciences LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0056418).

Company details

LLPIN AAY-5221
Incorporation Date 09 September 2021
Total Obligation of Contribution ₹1 Lakh
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2024
Date of Balance Sheet 31 March 2023
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-MH-23-0056418

Recognitions & Rankings of Ashvattas Life Sciences

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-23-0056418

Contact details

Ashvattas Life Sciences LLP's registered office is in Nashik, Maharashtra.

  • Registered Address
    Pl No. Nalanda Co Op Hsg Behind Bhimnagar Jail Road Nashik Road, Maharashtra, India – 422101
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Ashvattas Life Sciences LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Ashvattas Life Sciences LLP

FY 2023 filings available

Ashvattas Life Sciences LLP reported revenue of ₹10.11 Cr (up 162% YoY) for FY 2023.

Revenue · FY 2023
₹10.11 Cr ▲ 162%
Net profit · FY 2023
₹39.06 Lakh margin 3.9%
EBITDA · FY 2023
₹44.86 Lakh margin 4.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 162%
EBITDA CAGR growth
1 year
▲ 49%

Revenue rose 162% in the latest year. EBITDA rose 49% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23FY 2021-22
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax₹39.06 Lakh
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23FY 2021-22
Profitability
Net Profit Margin3.9%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Ashvattas Life Sciences LLP, buy the company report.

Designated partners of Ashvattas Life Sciences LLP

Ashvattas Life Sciences has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Rajat Gotulal AgrawalDesignated Partner09 Sep 20215 Years 1 MonthsCurrent
Tilak Rahul AgrawalDesignated Partner01 Apr 20242 Years 6 MonthsCurrent

Peer comparison

Ashvattas Life Sciences LLP is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Dmcare Pharma Private Limited₹10.19 Cr (FY 2025)130.0%Ahmedabad, Gujarat, India
PMV Lifescience Private Limited₹10.19 Cr (FY 2025)24.0%Mumbai, Maharashtra, India
Floreat Medica Private Limited₹10.19 Cr (FY 2025)4.0%Angamaly, Kerala, India
R.G. Pharma Healthcare Private Limited₹10.14 Cr (FY 2025)12.0%Jammu, Jammu and Kashmir, India
Zen Bio Tech Private Limited₹10.13 Cr (FY 2025)5.0%Hyderabad, Telangana, India
Ashvattas Life Sciences LLPthis company₹10.11 Cr (FY 2023)₹39.06 Lakh3.9%162.0%Nashik, Maharashtra, India
Saturn Formulations Private Limited₹10.09 Cr (FY 2024)10.0%Chandigarh, India
H.L.Healthcare Private Limited₹10.08 Cr (FY 2024)-16.0%Jalandhar, Punjab, India
Vaividhya Lifescience Private Limited₹10.03 Cr (FY 2025)37.0%Kadi, Gujarat, India
Lustre Pharmaceuticals Private Limited₹10.03 Cr (FY 2025)8.0%Ahmedabad, Gujarat, India
Medorganics India Private Limited₹10.02 Cr (FY 2024)15.0%Mangalore, Karnataka, India

To see the full peer comparison of Ashvattas Life Sciences LLP, buy the company report.

Charges & borrowings

Open charges
₹3.5 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹3.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Jan 2025101035172State Bank of India₹3.5 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ashvattas Life Sciences LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ashvattas Life Sciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27ABWFA4241J1Z2MaharashtraActive15 Dec 2021

To see the full GST registrations and return filing status of Ashvattas Life Sciences LLP, buy the company report.

Recent activity

Ashvattas Life Sciences LLP has 3 designated partner changes on record since 2021: 2 appointments and 1 cessation. The latest: Sudhir Namdeo Dhivare ceased to be Designated Partner on 01 Apr 2024.

Charges
A charge with State Bank Of India amounted to Rs. 350.00 Lakh with Charge ID 101035172 was registered on 06 Jan 2025.
Ceased
Sudhir Namdeo Dhivare ceased to be Designated Partner.
Appointed
Tilak Rahul Agrawal was appointed as Designated Partner.
AGM
Ashvattas Life Sciences Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records.
Filing
Ashvattas Life Sciences Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Appointed
Rajat Gotulal Agrawal was appointed as Designated Partner.
Incorporation
09 Sep 2021
Ashvattas Life Sciences Llp was registered on 09 Sep 2021 with Roc Mumbai & aged 5 years 1 month as per MCA records.

Frequently asked questions

Ashvattas Life Sciences is an active limited liability partnership based in Nashik, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 09 September 2021 (5+ years old) and is registered under LLPIN AAY-5221.

Ashvattas Life Sciences has 2 current designated partners:

The latest financial statements of Ashvattas Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 March 2024. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Ashvattas Life Sciences is 27ABWFA4241J1Z2, registered in Maharashtra.

The LLPIN (Limited Liability Partnership Identification Number) of Ashvattas Life Sciences is AAY-5221. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Ashvattas Life Sciences was incorporated on 09 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Ashvattas Life Sciences by revenue are Dmcare Pharma Private Limited, PMV Lifescience Private Limited, Floreat Medica Private Limited, R.G. Pharma Healthcare Private Limited, Zen Bio Tech Private Limited and 5 more, all in the Pharma industry (Formulations).

Sudhir Namdeo Dhivare ceased to be Designated Partner on 01 Apr 2024. Tilak Rahul Agrawal was appointed as Designated Partner on 01 Apr 2024. Rajat Gotulal Agrawal was appointed as Designated Partner on 09 Sep 2021.

Yes, Ashvattas Life Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Ashvattas Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-MH-23-0056418).

The registered office of Ashvattas Life Sciences is at Pl No. Nalanda Co Op Hsg Behind Bhimnagar Jail Road Nashik Road, Maharashtra, India – 422101.